RCP168
Product Specifications
Target
CXCR
Related Pathways
Autophagy, GPCR/G Protein, Immunology/Inflammation
Bioactivity
RCP168 is a highly selective and potent CXCR4 receptor antagonist with an IC50 of 5 nM. It exhibits superior capacity to inhibit HIV-1 (Human Immunodeficiency Virus type 1) from entering host cells via the CXCR4 receptor compared to natural chemokines. RCP168 suppresses HIV-1 infection by blocking viral binding sites or inducing receptor internalization. It can be utilized in research to study interactions between the CXCR4 receptor and other chemokine receptors.
Molecular Formula
C365H585N105O95S5
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM2060-50 1x 50 µL
PAX5 / BSAP (Early B-Cell Marker) (PAX5/2060), 1mg/mL
Sign In for Pricing
View Details 
